Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Regulatory News (PXS)

Share Price Information for Provexis (PXS)

Share Price is delayed by 15 minutes
Get Live Data
1.25    0.00 (0.00%)
Bid:
1.10
Ask:
1.25
Spread: 0.15 (13.636%)
Market Cap: £29.32m
PXS Live PriceLast checked at - London Stock Exchange

Intraday Provexis Share Chart

Directorate Change

4 May 2007 14:35

Provexis PLC04 May 2007 4 May 2007 PROVEXIS PLC ("Provexis" or the "Company") Directorate Change Provexis plc (ticker PXS.L), the nutraceutical company that developsscientifically-proven functional and medical foods, has appointed Jonathan BrettDiggines to its Board as a non-executive director with immediate effect. Jonathan Diggines, 54, is Chief Executive Officer of Enterprise Ventures GroupLimited, a 19.4 per cent shareholder in the Company. Jonathan, who is asolicitor, joined Enterprise Ventures in 2005 and had previously spent 10 yearsas Managing Director of Murray Johnstone Private Equity where he managedsubstantial private equity and venture funds. Jonathan holds or has held thefollowing directorships or been a partner in the following partnerships withinthe five years prior to this announcement: • Enterprise Ventures (General Partner Coalfields) Limited • Enterprise Ventures (General Partner EVF/LEV) Limited • Enterprise Ventures (General Partner HSBC European Fund) Limited • Enterprise Ventures (General Partner HSBC UK Enterprise Fund) Limited • Enterprise Ventures (General Partner Rising Stars) Limited • Enterprise Ventures (General Partner Rising Stars II) Limited • Enterprise Ventures Limited • Enterprise Ventures Group Limited • Enterprise Ventures Nominees Limited • LE Founders Limited • LE Founders II Limited • LE Founders III Limited • Nichols plc • North West Enterprise Investment Limited • Rising Stars Growth Fund Limited • Carbutt & Co. (1928) Limited • LE Founders Limited • MJPAP (Syndications) Limited • MJPAP II (Syndications) Limited • T F Willow Limited • Weigh A Way Limited • W F P Willow Limited • W G Willow Limited • W I Willow Limited • W Willow Limited • British Venture Capital Association • RAL (S&G) Limited • Sumit Venture Fund One Limited • STF Management Limited • SEV Investments Limited • SEV Holdings Limited • BIG (General Partner) Limited • Regent Street Ventures Limited • Aberdeen Murray Johnstone Private Equity Limited • Euractions Management Limited • Murray Johnstone Limited • Callform Limited • Aberdeen Growth Opportunities VCT PLC • M J Founders Limited • COIP (GB) Limited • Aberdeen Asset Managers Limited • AMJPEF Founder Partner Limited • AMJPEF GP Limited There are no further disclosures to be made in accordance with Schedule 2(g) ofthe AIM Rules. Dawson Buck, Chairman of Provexis said: "I am delighted that Jonathan Diggineshas joined the Board of Provexis. He brings a considerable wealth of experiencegained from his management of venture funds and from his portfolio ofnon-executive director roles both in public and private companies, including anumber of significant food and drink sector investments. These attributescombined with his standing in the private equity and venture capital industrywill add significant value to the strategic development of our proprietarytechnologies." - ENDS - Enquiries: Provexis PlcStephen Moon, Chief Executive Officer 020 8392 6634 Arbuthnot SecuritiesTom GriffithsAlasdair Younie 020 7012 2000 Adventis Financial PRChris Steele 020 7034 4759Annie Evangeli 020 7034 4757 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Jan 202112:37 pmRNSHalf-year Report
31st Dec 20201:00 pmRNSTotal Voting Rights
17th Dec 20207:00 amRNS£1m placing & update re HY results
16th Nov 20207:00 amRNSExclusive Distribution Agreement for Chinese CBEC
30th Oct 20202:09 pmRNSResult of AGM
30th Sep 20207:00 amRNSFinal Results
28th Aug 20205:00 pmRNSTotal Voting Rights
13th Aug 20207:00 amRNSFruitflow® & Blood Pressure - purchase of IP
7th Aug 20205:11 pmRNSHolding(s) in Company
27th May 20207:00 amRNSHolding(s) in Company
31st Dec 20197:13 amRNSInterim Results and Total Voting Rights
11th Dec 20197:00 amRNSPlacing of new ordinary shares to raise £0.301m
4th Oct 20191:19 pmRNSResult of AGM
12th Sep 20193:19 pmRNSDirector/PDMR Shareholding
11th Sep 20194:02 pmRNSGrant of Share Options
10th Sep 20197:00 amRNSFinal Results
2nd Aug 20197:00 amRNSCollaboration agreement with By-Health Co., Ltd.
31st Jul 20197:00 amRNSTrading Update
27th Jun 20193:11 pmRNSTiming of trading update
12th Apr 20197:00 amRNSBoard changes
8th Mar 20199:44 amRNSHolding(s) in Company
31st Dec 20187:00 amRNSHalf-year Report
1st Nov 20181:00 pmRNSChange of Adviser and AIM Rule 17 notice
25th Oct 20181:55 pmRNSResult of AGM
16th Oct 20187:00 amRNSHolding(s) in Company
9th Oct 20184:25 pmRNSHolding(s) in Company
27th Sep 20187:10 amRNSFinal Results
27th Sep 20187:00 amRNSResults of Placing
4th Jul 20187:00 amRNSDirectorate Change - Frédéric Boned
25th Jun 20187:00 amRNSFruitflow®+ Omega-3 launch in Holland & Barrett
5th Feb 20182:16 pmRNSHolding(s) in Company
31st Jan 20188:21 amRNSDirectorate Change - Krijn Rietveld
2nd Jan 20187:00 amRNSGrant of Share Options
29th Dec 20177:09 amRNSHalf-year Report
4th Dec 20177:00 amRNSPatent application - Fruitflow and air pollution
10th Nov 20174:40 pmRNSSecond Price Monitoring Extn
10th Nov 20174:35 pmRNSPrice Monitoring Extension
2nd Nov 20174:41 pmRNSSecond Price Monitoring Extn
2nd Nov 20174:35 pmRNSPrice Monitoring Extension
31st Oct 20174:40 pmRNSSecond Price Monitoring Extn
31st Oct 20174:35 pmRNSPrice Monitoring Extension
3rd Oct 20174:10 pmRNSResult of AGM
26th Sep 20172:44 pmRNSStudy Publication
7th Sep 20177:00 amRNSPreliminary Results
4th Aug 20178:00 amRNSHolding(s) in Company
31st Jul 20177:59 amRNSResults of placing
28th Jul 20174:30 pmRNSFunding Update
3rd Jul 20177:00 amRNSFunding Update
9th Jun 20174:35 pmRNSPrice Monitoring Extension
5th Jun 20174:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.